title: Generic drug scandals raise questions about safety. FDA reorganizes to increase surveillance, prevent fraud.
authors.forename: S
authors.initials: S
authors.lastname: Martin
mesh_terms: D003257:Consumer Product Safety; D004346:Drug Information Services; D006801:Humans; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration